Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Gut|August 16, 2018
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trialRoser Pinyol, Robert Montal, Laia Bassaganyas, et al.
Lancet (London, England)|May 11, 2025
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trialThomas Yau, Peter R Galle, Thomas Decaens, et al.
The Lancet. Gastroenterology & Hepatology|May 22, 2026
The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729-001): a phase 1a/b trialMan-Fung Yuen, Edward Gane, Jacinta A Holmes, et al.
The New England Journal of Medicine|January 8, 2025
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis BJinlin Hou, Wenhong Zhang, Qing Xie, et al.
The New England Journal of Medicine|July 5, 2018
Inotersen Treatment for Patients with Hereditary Transthyretin AmyloidosisMerrill D Benson, Márcia Waddington-Cruz, John L Berk, et al.
The New England Journal of Medicine|January 25, 2018
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 InfectionStefan Zeuzem, Graham R Foster, Stanley Wang, et al.
The New England Journal of Medicine|May 28, 2026
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus InfectionJinlin Hou, Seng-Gee Lim, Maria Buti, et al.
Pageof 13